Medicine & Life Sciences
Urinary Bladder Neoplasms
100%
Carcinoma
72%
Cisplatin
46%
Drug Therapy
45%
Neoplasms
45%
Survival
33%
Muscles
30%
Cystectomy
27%
Prostatic Neoplasms
26%
Urinary Bladder
22%
pembrolizumab
21%
Platinum
21%
Therapeutics
20%
Docetaxel
14%
enfortumab vedotin
13%
Clinical Trials
13%
Canidae
13%
Immunotherapy
13%
durvalumab
11%
Carcinoma in Situ
11%
atezolizumab
11%
Bacillus
11%
Progression-Free Survival
11%
gemcitabine
10%
Mycobacterium bovis
9%
Biomarkers
8%
Nephroureterectomy
8%
Histology
7%
Prostate-Specific Antigen
7%
Androgens
7%
Safety
7%
Dogs
7%
Nivolumab
6%
Systematic Reviews
6%
Epigenomics
6%
Confidence Intervals
6%
Hormones
6%
Genes
5%
Renal Cell Carcinoma
5%
Combination Drug Therapy
5%
Everolimus
5%
Mutation
5%
Circulating Neoplastic Cells
5%
Nectins
5%
Recurrence
5%
Nomograms
5%
Bevacizumab
5%
Immunoconjugates
5%
Radiotherapy
5%
BNC 105P
5%